Adesis

Adesis is a specialized CDMO providing high-value chemistry services to accelerate drug and technology development for its clients. Founded in 1991 and now a subsidiary of Universal Display Corporation, it operates with a highly skilled R&D team (~80% PhD scientists) and 100% US-based facilities. Its business model is focused on providing agile, integrated contract research and manufacturing services, positioning it as a strategic partner for companies needing expertise in complex small molecule and peptide synthesis.

Integrated chemistry services platform encompassing discovery chemistry, process chemistry, specialty manufacturing, and custom peptide synthesis, supported by a team of highly qualified PhD scientists.

Adesis competes in a fragmented CDMO market against large global players (e.g., Lonza, Catalent) and numerous smaller, specialized chemistry firms. Its differentiation lies in its deep scientific expertise, agile service model, US-based operations, and the financial backing of its publicly-traded parent company.